Open To Work
Karan Sharma
Work Preference
Summary
Results-driven Business Development Director in the pharmaceutical industry, securing USD 50 million in new business. Specializes in partner negotiation and customer relationship management, driving growth through strategic market analysis and cross-functional collaboration. Excels in sales forecasting and consistently meets targets while fostering long-term partnerships.
Overview
17
17
years of professional experience
Work History
Business development director (EU & ROW)
Extrovis
05.2024 - Current
- Secured USD 10 million in new business by exploring international opportunities.
- Proactively managed target and budget sales achievements, exceeding goals.
- Managed cross-functional teams to execute business development initiatives.
- Identified and coordinated with partners for CMO services, enhancing collaboration.
- Maintained existing customer relationships, driving long-term growth.
Business development for Biosimilar (Global)
Intas Pharmaceuticals
03.2023 - 04.2024
- Identified new business opportunities and operationalized entry into new countries, generating USD 20 million in new business.
- Directed efforts to meet sales targets and budget requirements.
- Managed customer accounts to drive satisfaction and retention.
- Coordinated regulatory filings between customer and R&D for timely dossier submission and approval.
Business development- Regulated market FDF (EU, USA, Australia & Canada)
Laurus Labs
09.2019 - 02.2023
- Identified new business opportunities, generating USD 15 million with five new partners.
- Executed business development activities for regulated markets, contributing to target sales achievement.
- Cultivated existing customer relationships, coordinating effectively with internal and external stakeholders.
- Developed launch strategies for newly approved products in US and EU markets.
- Closed business agreements with partners requiring CMO services.
- Negotiated pricing for tenders, ensuring timely deliveries through collaboration with suppliers.
- Forecasted and placed internal purchase orders based on demand and launch plans.
- Ensured adequate inventory levels in regional warehouses to prevent penalties.
- Supported US and EU B2C operations by assisting portfolio identification efforts.
Business development- EU FDF
Jubilant Generics
12.2014 - 09.2019
- Identified new business opportunities and operationalized entry into new countries, generating USD 5 million in revenue through partnerships with five new partners.
- Executed business development initiatives in European markets, resulting in expanded market presence.
- Drove target sales achievement across European markets.
- Managed portfolio of 25 existing customers across EU, fostering strong client relationships.
- Regulatory: Coordinating all activity related to regulatory filings between customer & Jubilant R&D for timely dossier submission & approval
- Coordinated with supply chain and plant teams to ensure timely deliveries.
Business analyst
Jubilant Generics
05.2009 - 12.2014
- Have been at the forefront of closing the budget & strategy for FDF business for almost 10 years.
- Prepared monthly BPR (Business performance report) for CEO/MD analysis.
- Conducted analysis to assist business head in evaluating proposed plans and strategies.
- Developed 5-year strategy plan and validated with IMS data.
- Prepared annual budget in collaboration with the finance team
- Preparation of COGS in discussion with finance
- Preparation of proposal for the regional heads
- Analyzing the monthly performance of regions
Education
Masters - Business Administration
Amity Business School
Noida04-2009
Bachelors - Commerce
Delhi University
Delhi04-2007
Skills
- Business development
- Sales strategy development
- Market analysis
- Sales forecasting
- Partner negotiation
- Lead generation
- Customer acquisition
- Client relationship management
- Cross-functional collaboration
- Regulatory compliance
Timeline
Business development director (EU & ROW)
Extrovis
05.2024 - Current
Business development for Biosimilar (Global)
Intas Pharmaceuticals
03.2023 - 04.2024
Business development- Regulated market FDF (EU, USA, Australia & Canada)
Laurus Labs
09.2019 - 02.2023
Business development- EU FDF
Jubilant Generics
12.2014 - 09.2019
Business analyst
Jubilant Generics
05.2009 - 12.2014
Masters - Business Administration
Amity Business School
Bachelors - Commerce
Delhi University